MagAssist was included in the catalogue of "Advantageous Enterprises in the Fourth Batch of Intellectual Property Strong Companies Cultivation Project in Suzhou City".

In order to further implement the intellectual property strong enterprise cultivation project and establish the "Suzhou City Intellectual Property Strong Companies Cultivation Project Management Platform", Recently, the Suzhou Municipal Market Supervision Administration (Suzhou Intellectual Property Office) released the list of enterprises in the fourth batch of intellectual property strong companies cultivation project in Suzhou City.With its sound intellectual property management system and fruitful patent achievements, magAssist was successfully selected into the catalogue of intellectual property advantageous enterprises in Suzhou City.

2023 The Fourth Batch of Key Companies Protection List of Intellectual Property in Suzhou City

The intellectual property strong companies cultivation project aims to enhance the core competitiveness of enterprises, with the goal of cultivating a batch of landmark strong companies in intellectual property and supporting the high-quality economic development with strong intellectual property work.

magAssist has won many intellectual property-related honors including "2023 Outstanding Intellectual Property Management Team in China" and "2023 The Fourth Batch of Key Companies Protection List of Intellectual Property in Suzhou City"! 

As an innovative enterprise integrating R & D, production and sales in the field of life support, magAssist, while committed to exploring the transformation of cutting-edge technologies and products, has established a sound intellectual property management system. So far, it has applied for more than 300 patents, and nearly 200 patents domestically and internationally in the past two years. It has an international patent layout in major countries such as the United States and Europe, providing important intellectual property reserves and strategic support for the international development of independent innovation enterprises. 

Starting from heart failure, magAssist is building a multi-organ life support platform. The currently released product lines mainly include the fully magnetically levitated extracorporeal artificial heart MoyoAssist® Extra VAD®, the minimally invasive interventional artificial heart NyokAssist® pVAD and the new generation of extracorporeal membrane oxygenation system BreathMo® ECMO.

These products are in different stages. MoyoAssist® Extra VAD® was approved by NMPA for marketing in April this year; NyokAssist® pVAD has been successively recognized as a "breakthrough device" by the FDA and an innovative medical device by NMPA, and is currently under clinical trial;BreathMo® ECMO has completed clinical trial and won the Jiangsu Province Science and Technology Achievement Transformation Project in 2023.

In the future, magAssist will continue to work intensively in the field of intellectual property, so that the power of intellectual property can be transformed into more cutting-edge technologies and live saving products.